Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Chad A, Hall"'
Autor:
Scott Goode, Sandra Orsulic, Susan G. Hilsenbeck, Thomas Wheeler, Xiaoyun Shen, Esther Oliva, Jiangyong Miao, Runsheng Wang, Chad A. Hall
The Hippo pathway regulates organ size and tumorigenesis in Drosophila and mammals and is altered in a variety of human cancers, yet it remains unclear if the Hippo pathway is of prognostic significance to cancer patients. Here we show that the key t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::419d60f30da71e9e59ef8a5d4eef7cdd
https://doi.org/10.1158/0008-5472.c.6500892
https://doi.org/10.1158/0008-5472.c.6500892
Autor:
Scott Goode, Sandra Orsulic, Susan G. Hilsenbeck, Thomas Wheeler, Xiaoyun Shen, Esther Oliva, Jiangyong Miao, Runsheng Wang, Chad A. Hall
Supplementary Figure 1 from Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5498f2fdb06122511e093ea4eb470e0a
https://doi.org/10.1158/0008-5472.22384425.v1
https://doi.org/10.1158/0008-5472.22384425.v1
Autor:
Chad A, Hall, Rachel H, Kravitz, Karl F, Johnson, Nicholas A, Sanek, Payel, Maiti, Keith R, Ziemba, Jia, Liu, Dmitri O, Andreev, Victoria L, Chrostowski, Ian J, Collins, Gregory T, Bleck
Publikováno v:
Biotechnology and Bioengineering.
Reducing drug development timelines is an industry-wide goal to bring medicines to patients in need more quickly. This was exemplified in the COVID-19 pandemic where reducing development timelines had a direct impact on the number of lives lost to th
Autor:
Chad A. Hall, Rachel H. Kravitz, Karl F. Johnson, Nicholas A. Sanek, Payel Maiti, Keith R. Ziemba, Jia Liu, Dmitri O. Andreev, Victoria L. Chrostowski, Ian J. Collins, Gregory Bleck
Reducing drug development timelines is an industry-wide goal to bring medicines to patients in need more quickly. This was exemplified in the COVID-19 pandemic where reducing development timelines had a direct impact on the number of lives lost to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::310d98789acba42e7cfcc7a01813a992
https://doi.org/10.22541/au.167113298.81559773/v1
https://doi.org/10.22541/au.167113298.81559773/v1
Autor:
Chad Patrick Hall
Publikováno v:
Proceedings of the Annual Meetings on Phonology. 8
This study tests the P-Map’s (Steriade, 2001) hypothesis that attested phonological patterns vary depending on phonological context due to differences in the perceptual similarity of two phonological contrasts in different contexts, and that the kn
Autor:
Chad Chad Hall
Publikováno v:
Matices en Lenguas Extranjeras. :132-153
Este trabajo analizó la producción del fonema /r/ de los adolescentes anglo-ingleses y punjabí-ingleses bilingües en el oeste de Yorkshire a partir de los datos recogidos en el año 2000. Se encontró una clara diferencia entre los hablantes angl
Autor:
James R. Prudent, Fabio Malavasi, Mohammed S. Shekhani, John L Murphy, Chad A Hall, Antonella Chillemi, David J. Marshall, Christophe Pain, Jon S. Thorson, Conner A Lyons, Homer L Pearce, Scott Harried
Publikováno v:
Molecular Therapy
The human Na+/K+-ATPase (NKA) is a plasma membrane ion pump that uses ATP to help maintain the resting potential of all human cells. Inhibition of the NKA leads to cell swelling and death. The results of this investigation show that on cancer cells,
Publikováno v:
The American surgeon. 84(4)
The oncologic benefit of a central lymph node dissection (CLND) at the time of modified radical neck dissection (MRND) in patients with papillary thyroid cancer who have previously undergone a total thyroidectomy (TT) has not been studied. Patients w
Publikováno v:
Genetics. 178:1947-1971
Fasciclin2 (Fas2) and Discslarge (Dlg) localize to the basolateral junction (BLJ) of Drosophila follicle epithelial cells and inhibit their proliferation and invasion. To identify a BLJ signaling pathway we completed a genomewide screen for mutants t
Publikováno v:
Cancer Research. 76:2964-2964
Purpose: CD20 is known to be a therapeutic antibody drug target as it is expressed on the surface of most B-cell neoplasms. Here, we assessed the anti-tumor activity of EDC9, a novel extracellular drug conjugate composed of Rituximab (a well know and